Cassie Gorsuch
About Cassie Gorsuch
Cassie Gorsuch is an Associate Director at Precision BioSciences, Inc., where she has worked since 2020. She holds a PhD in Biological Sciences from the University of Notre Dame and has extensive experience in academia and the biotechnology industry.
Current Role at Precision BioSciences
Cassie Gorsuch serves as the Associate Director at Precision BioSciences, Inc., a position she has held since 2020. In this role, she oversees various projects and initiatives within the organization. Additionally, she holds the title of Vice President of Gene Therapy, contributing to the strategic direction and development of gene therapy programs.
Previous Experience at Precision BioSciences
Prior to her current role, Cassie Gorsuch worked at Precision BioSciences in several capacities. She was a Research Scientist from 2017 to 2019 and then became Team Leader for Therapeutic Discovery from 2019 to 2020. Her tenure at Precision BioSciences has involved significant contributions to research and development in the field of gene therapy.
Educational Background
Cassie Gorsuch earned her Doctor of Philosophy (PhD) in Biological Sciences from the University of Notre Dame, where she studied from 2010 to 2015. She also holds a Bachelor of Science (BS) in Biochemistry from Rockhurst University, which she completed from 2006 to 2010. Her academic background has provided a strong foundation for her career in the life sciences.
Teaching Experience
Cassie Gorsuch has extensive teaching experience in higher education. She served as a Graduate Teaching Assistant at the University of Notre Dame from 2010 to 2013 and as a Teaching Assistant at Rockhurst University from 2007 to 2009. These roles involved supporting faculty and assisting students in their learning processes.
Research Presentations
Cassie Gorsuch has presented her research at several prestigious conferences. She presented at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress and shared preclinical data at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting, as well as the American Society of Gene & Cell Therapy 26th Annual Meeting. These presentations highlight her active engagement in the scientific community.